Suchergebnisse - "Appleby, Niamh"

PubPharm (18)

1

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

enthalten in: Nature genetics | 2022

von Robbe, P. | Ridout, K. | Vavoulis, D. | +140

2

Differential genomic and transcriptomic events associated with high-grade transformation of Chronic Lymphocytic Leukemia

enthalten in: bioRxiv.org | 2022

von Klintman, J. | Stamatopoulos, B. | Ridout, K. | +14

3

Cellular Therapy in High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter Syndrome

enthalten in: Frontiers in oncology | 2022

von Barbanti, M. | Appleby, N. | Kesavan, M. | +1

4

Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia

enthalten in: Blood | 2021

von Klintman, J. | Appleby, N. | Stamatopoulos, B. | +16

CommentIn: Hematol Oncol. 2022 Apr;40(2):302-306. - PMID 34806797

5

The STELLAR trial protocol : a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

enthalten in: BMC cancer | 2019

von Appleby, N. | Eyre, T. | Cabes, M. | +7

6

The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

enthalten in: BMC cancer | 2019

von Appleby, N. | Eyre, T. | Cabes, M. | +7

7

The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

enthalten in: BMC cancer | 2019

von Appleby, N. | Eyre, T. | Cabes, M. | +7

8

FIP1L1-PDGFRα p.T674I-D842L : A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia

enthalten in: HemaSphere | 2019

von Lierman, E. | Smits, S. | Appleby, N. | +3

9

Guideline for the treatment of chronic lymphocytic leukaemia : A British Society for Haematology Guideline

enthalten in: British journal of haematology | 2018

von Schuh, A. | Parry-Jones, N. | Appleby, N. | +14

10

Risk adjusted therapy in chronic lymphocytic leukemia : a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL

enthalten in: Leukemia & lymphoma | 2018

von Appleby, N. | O'Brien, D. | Quinn, F. | +14